Thus, the current work with 3745 CRCs was performed to determine the survival impact of SOX2 expression on CRC ((cancer-specific survival (CSS), overall survival (OS), and disease-free survival (DFS)) and to evaluate the association between SOX2 expression and general clinicopathological characteristics. Here, SOX2 is linked to colorectal carcinoma.